Overview
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.
Indication
For the acute treatment of migraine attacks with or without aura in adults.
Associated Conditions
- Migraine With Aura
- Migraine Without Aura
- Migraine;Menstrual
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2010/01/07 | Phase 2 | Completed | |||
2009/12/21 | Phase 3 | Completed | Endo Pharmaceuticals | ||
2009/05/19 | Phase 4 | Completed | Endo Pharmaceuticals | ||
2009/02/18 | Phase 4 | Completed | |||
2009/01/13 | Phase 3 | Completed | |||
2008/06/18 | Not Applicable | Completed | Scott and White Hospital & Clinic | ||
2008/03/26 | Phase 3 | Completed | Endo Pharmaceuticals | ||
2007/05/21 | Phase 3 | Completed | Endo Pharmaceuticals | ||
2007/02/26 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Frovatriptan succinate Tablets | 国药准字H20244535 | 化学药品 | 片剂 | 7/30/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.